Elizabeth C. Saunders, PhD
Senior Research Scientist, Center for Technology and Behavioral Health
Elizabeth Saunders is a Senior Research Scientist at the Center for Technology and Behavioral Health (CTBH). Elizabeth earned her PhD from the Dartmouth Institute (TDI) for Health Policy and Clinical Practice. Her mixed-methods dissertation research examined preferences for medication for opioid use disorder (MOUD) using web-based sampling strategies. Elizabeth’s research interests include the evaluation and implementation of treatment for opioid use disorder (OUD) using qualitative and quantitative methods. In her free time, she enjoys playing music, reading, and spending time outside with her family.
Selected Publications
- Saunders EC, Moore SK, Walsh O, Metcalf SA, Budney AJ, Scherer E, Marsch LA. Perceptions and preferences for long-acting injectable and implantable medications in comparison to short-acting medications for opioid use disorders. J Subst Abuse Treat. 2020 Apr;111:54-66. doi: 10.1016/j.jsat.2020.01.009. PMID: 32076361.
- Marsch LA, Campbell A, Campbell C, Chen CH, Ertin E, Ghitza U, Lambert-Harris C, Hassanpour S, Holtyn AF, Hser YI, Jacobs P, Klausner JD, Lemley S, Kotz D, Meier A, McLeman B, McNeely J, Mishra V, Mooney L, Nunes E, Stafylis C, Stanger C, Saunders EC, Subramaniam G, Young S. The application of digital health to the assessment and treatment of substance use disorders: The past, current, and future role of the National Drug Abuse Treatment Clinical Trials Network. J Subst Abuse Treat. 2020 Mar;112S:4-11. doi: 10.1016/j.jsat.2020.02.005. PMID: 32220409.
- Goodman DJ, Saunders EC, Wolff KB. In their own words: A qualitative study of factors promoting resilience and recovery among postpartum women with opioid use disorders. BMC Pregnancy Childbirth. 2020 Mar 18;20(1):178. doi: 10.1186/s12884-020-02872-5. PMID: 32188411.
- Meier A, Moore SK, Saunders EC, McLeman B, Metcalf SA, Auty S, Walsh O, Marsch LA. Understanding the increase in opioid overdoses in New Hampshire: A rapid epidemiologic assessment. Drug Alcohol Depend. 2020 Feb 7;209:107893. doi:10.1016/j.drugalcdep.2020.107893. PMID: 32065941.
- Bessen S, Metcalf SA, Saunders EC, Moore SK, Meier A, McLeman B, Walsh O, Marsch LA. Barriers to naloxone use and acceptance among opioid users, first responders, and emergency department providers in New Hampshire, USA. Int J Drug Policy. 2019 Oct 4;74:144-151. doi: 10.1016/j.drugpo.2019.09.008. PMID: 31590090.
- Saunders EC, Metcalf SA, Walsh O, Moore SK, Meier A, McLeman B, Auty S, Bessen S, Marsch LA. "You can see those concentric rings going out": Emergency personnel's experiences treating overdose and perspectives on policy-level responses to the opioid crisis in New Hampshire. Drug and Alcohol Dependence. Available online 13 September 2019. doi: 10.1016/j.drugalcdep.2019.107555. PMID: 31542630.
- Saunders EC, Moore SK, Gardner T, Farkas S, Marsch LA, McLeman B, Meier A, Nesin N, Rotrosen J, Walsh O, McNeely J. Screening for substance use in rural primary care: A qualitative study of providers and patients. J Gen Intern Med. 2019 Aug 14. doi: 10.1007/s11606-019-05232-y. PMID: 31414355.
- Holtyn AF, Bosworth E, Marsch LA, McLeman B, Meier A, Saunders EC, Ertin E, Ullah MA, Samiei SA, Hossain M, Kumar S, Preston KL, Vahabzadeh M, Shmueli-Blumberg D, Collins J, McCormack J, Ghitza UE. Towards detecting cocaine use using smartwatches in the NIDA clinical trials network: Design, rationale, and methodology. Contemp Clin Trials Commun. 2019 Jun 4;15:100392. doi: 10.1016/j.conctc.2019.100392. eCollection 2019 Sep. PMID: 31245651.
- Capone C, Presseau C, Saunders EC, Eaton E, Hamblen J, McGovern MP. Is integrated CBT effective in reducing PTSD symptoms and substance use in Iraq and Afghanistan veterans? Results from a randomized trial. Cognitive Therapy and Research. Cognitive Therapy and Research, 42, 735-746, doi: 10.1007/s10608-018-9931-8.
- Nordstrom BR, Saunders EC, McLeman B, Meier A, Xie H, Lambert-Harris C, Tanzman B, Brooklyn J, King G, Kloster N, Lord CF, Roberts W, McGovern MP. Using a learning collaborative strategy with office-based practices to increase access and improve quality of care for patients with opioid use disorders. J Addict Med. 2016 Mar-Apr;10(2):117-23. doi: 10.1097/ADM.0000000000000200. PMID: 26900669; PMCID: PMC4865252.